Charles Schwab Investment Management Inc Guardant Health, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,013,272 shares of GH stock, worth $55.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,013,272
Previous 996,506
1.68%
Holding current value
$55.8 Million
Previous $42.5 Million
24.21%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding GH
# of Institutions
415Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$234 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...